The Designing of a Gel Formulation with Chitosan Polymer Using Liposomes as Nanocarriers of Amphotericin B for a Non-invasive Treatment Model of Cutaneous Leishmaniasis

In Vitro and In Vivo Effects of Conventional and Chitosan Nanoparticle-Encapsulated Miltefosine Drug for Treatment of Cutaneous Leishmaniasis

“…The zeta potential of MLCNPs was +1.04 mV. In a previously published study, the zeta potentials of liposomal-based formulation were in the range of −8.2 ± 3.50 mV, which is less than the chitosan nanoparticles of the current study [27].…”